What happens if you miss a dose of Ozempic or Mounjaro?

The short answer

Missing one GLP-1 dose is rarely a crisis, but how much it matters depends on the drug. A 2026 pharmacokinetic analysis found that semaglutide, the medicine in Ozempic and Wegovy, holds its blood level for about a week, so a single skipped dose barely moves it. Tirzepatide (Mounjaro, Zepbound), liraglutide and the oral pill orforglipron fade much faster. Whatever you take, follow your product's label and your prescriber, and never double up to catch up.

Why a missed dose matters more for some drugs than others

Every GLP-1 medication clears from your body at its own pace, measured as its half-life, the time it takes for the blood level to fall by half. The longer the half-life, the more forgiving the drug is when life gets in the way of a dose. Semaglutide has a half-life of about 7 days. Tirzepatide sits around 5 days. Liraglutide is roughly half a day, and the oral pill orforglipron is only 1 to 2 days.

That single number explains most of what follows. A drug that lingers for a week barely notices a skipped day. A drug that is mostly gone within a day or two can swing hard when you miss one.

What the 2026 study actually measured

The clearest data on this comes from a 2026 analysis in Diabetes, Obesity and Metabolism. It is worth knowing up front that the study was funded by Novo Nordisk, the maker of Ozempic and Wegovy, and four of its five authors are Novo employees and shareholders. That matters, because the headline conclusion happens to favour Novo's own semaglutide. We will come back to it. The underlying pharmacokinetics, though, are driven by half-life, which is a physical property of each molecule rather than a marketing claim.

The researchers did not run a new trial. They used published pharmacokinetic models to simulate the blood levels of five treatments, oral semaglutide, injectable semaglutide, liraglutide, tirzepatide and oral orforglipron, then played out what happens when a patient misses doses by 1, 3 or 7 days. The simulation was run on one reference person: a 45-year-old woman weighing 105 kg without type 2 diabetes.

Which GLP-1 drugs are most forgiving if you miss a dose

Here is how the five treatments behaved once a dose was skipped:

• Oral semaglutide (the daily pill): the blood level dropped by half only after 7 missed days.
• Injectable semaglutide (Ozempic, Wegovy): the same pattern, a meaningful drop only after about a week.
• Tirzepatide (Mounjaro, Zepbound): the level fell by half after a single missed dose.
• Liraglutide (Saxenda, Victoza): the level fell by half after a single missed dose.
• Orforglipron (the oral pill Foundayo): the level fell by half after a single missed dose.

In plain terms, semaglutide is the patient one. Miss a day, or even two, and your drug level barely changes. The others are less forgiving: one missed dose already cuts the amount of active drug roughly in half. For a once-weekly injection like tirzepatide, a single missed week is a bigger deal than a single missed day of a daily pill, because the whole week's exposure rests on that one shot.

The dosing schedule changes the stakes in a way the half-life numbers alone can hide. A once-daily drug gives you a fresh chance every 24 hours, so one forgotten day is quickly followed by the next scheduled dose. A once-weekly injection like Ozempic or Mounjaro has no such backstop, since the whole week leans on a single shot, and forgetting it leaves a longer gap before the next planned dose. That is why a steady day-of-the-week routine matters more for the weekly injectables than for a daily pill.

The bigger problem is restarting, not skipping

The drop in drug level is only half the story. The 2026 analysis found that restarting after a run of missed doses can send levels sharply back up. For liraglutide and orforglipron, exposure rebounded by roughly 400% to 700% when treatment resumed after 3 missed days. Semaglutide, by contrast, climbed back gradually.

Why does that matter? GLP-1 side effects like nausea, vomiting and diarrhoea are worst when your dose jumps, which is exactly why your prescriber starts you on a low dose and raises it slowly. A big rebound after missed doses mimics a sudden dose increase, so the nausea you had worked past can come back hard. It is the same reason stopping and restarting on your own is risky, something we cover in how to manage GLP-1 side effects without stopping the drug.

This is also why the labels differ. People taking liraglutide or orforglipron are told to restart at a lower dose after a stretch of missed doses, 3 missed days for liraglutide and 7 for orforglipron. Semaglutide, because it fades so slowly, carries no instruction to drop back down. The practical lesson is that the restart rules are drug-specific, and guessing is how people make themselves ill.

Does missing doses hurt your results?

Indirectly, yes, and the half-life story shows up in the weight-loss numbers too. In their trials, the shorter-acting drugs orforglipron and liraglutide produced body-weight reductions in the range of 7.8% to 12.4%. Longer-acting injectable semaglutide produced 16.9% to 20.7%. The authors argue that part of that gap may come down to how sensitive each drug is to imperfect dosing in the real world.

Treat that comparison with care. These figures come from different trials with different participants, so they are an indirect comparison, not a head-to-head. Tirzepatide, for instance, is highly effective despite its shorter half-life, probably because it acts on a second receptor called GIP rather than because of how long it lasts. Half-life is one piece of the puzzle, not the whole thing.

What to do if you miss a GLP-1 dose

The study compares molecules, not people, so it cannot tell you what to do tonight. These steps can:

1. Check your specific product's label first. Every GLP-1 drug has a missed-dose section, and the rules are not the same from one drug to the next. That is the place to look before you do anything else.
2. Do not double up to catch up. Taking two doses close together to make up for a missed one is exactly how the rebound effect above turns into a bout of nausea or vomiting.
3. Call your pharmacist or prescriber if more than a few days have passed. For the shorter-acting drugs especially, a longer gap may mean restarting at a lower dose, and that is a decision for your prescriber, not a guess.
4. Do not switch drugs on your own because one is "more forgiving." Which GLP-1 is right for you depends on your health, your insurance and how you tolerate it, and that choice belongs with your doctor.
5. Keep eating well through the gap. When dosing is erratic your appetite can swing, and so can your intake of the nutrients your body still needs.

Who funded this, and what it cannot tell you

Two honest caveats close this out. First, the funding. Novo Nordisk paid for the study, four of the five authors work for and own stock in the company, and the medical writing was Novo-funded too. The conclusion that Novo's semaglutide is the most practical choice should be read in that light. The pharmacokinetics themselves are solid, since half-life is physics, but the framing is the sponsor's.

Second, this was a computer simulation, not a study of real patients missing real doses. It modelled a single 45-year-old woman and did not account for differences in sex, body weight, diabetes status or gut bacteria, all of which can change how a drug behaves. The authors say plainly that real-world effects cannot be established from this analysis. Use it as a guide to the general pattern, not a promise about your own body.

One practical thread ties all of this to nutrition. Whether your dosing is perfectly consistent or full of gaps, long stretches of eating less can leave GLP-1 users short on nutrients like vitamin B12, vitamin D, iron and magnesium, and erratic dosing only makes intake more uneven. A supplement does not change your drug's half-life or how it handles a missed dose, but closing a real deficiency is worth tracking. Our monitoring guide for vitamins on GLP-1 lists the panel to ask for, and the repletion-first approach is what GLP-1 Shield is built around. If you want the fuller picture on the newest oral option, see our explainer on the Foundayo orforglipron pill.

Key takeaways

• A 2026 pharmacokinetic simulation found semaglutide (oral and injectable) loses half its exposure only after 7 missed days, while tirzepatide, liraglutide and orforglipron lose half after a single missed dose.
• Restarting matters more than skipping: liraglutide and orforglipron exposure rebounded roughly 400% to 700% after 3 missed days, which can trigger a fresh wave of nausea.
• The labels reflect this, with liraglutide and orforglipron requiring a lower restart dose after a run of missed days, while oral semaglutide does not.
• The study was funded by Novo Nordisk and most authors are employees, and it modelled one reference patient, so read the semaglutide-favouring conclusion with that in mind.
• If you miss a dose, check your product's label, never double up, and call your prescriber if more than a few days have passed.

Frequently asked questions

What happens if I miss a dose of Ozempic or Wegovy?

Missing one dose of Ozempic or Wegovy (injectable semaglutide) has little effect on your drug level, because semaglutide has a half-life of about 7 days. A 2026 pharmacokinetic simulation found exposure drops by half only after 7 missed days. The official guidance is to follow the missed-dose section of your product label; as a general rule, take a late weekly dose if your next one is still a couple of days away, and never take two doses close together.

How many days can you go without a GLP-1 before it stops working?

It depends on the drug's half-life. The 2026 simulation found semaglutide holds roughly half its level for about a week, while tirzepatide, liraglutide and orforglipron lose half their level after a single missed dose. So semaglutide tolerates a missed day or two with little change, but the shorter-acting drugs fade quickly. This describes drug levels, not a promise about your results, and your label and prescriber set the real limits.

Should I take my GLP-1 dose late or just skip it?

Check your product's label first, because the missed-dose rule differs by drug. From the pharmacokinetics, semaglutide (Ozempic, Wegovy) holds its level for about a week, so a late dose matters little, while tirzepatide, liraglutide and orforglipron fade within a day or two. Whatever you take, do not take two doses close together to catch up, since that can bring on nausea or vomiting.

Is Mounjaro less forgiving of a missed dose than Ozempic?

In the 2026 simulation, yes. Tirzepatide (Mounjaro, Zepbound) has a half-life of about 5 days and lost half its exposure after a single missed dose, while semaglutide (Ozempic, Wegovy) lost half only after 7 missed days. Both are once-weekly injections, so a missed week affects tirzepatide more. This is a reason to stay consistent, not to switch drugs on your own, which is a decision for your prescriber.